Bipartisan Bill Would Unlock User Fees For Drugs, Devices

Law360, New York (July 22, 2013, 5:37 PM EDT) -- Bipartisan legislation introduced Thursday in Congress would prevent sequestration from applying to user fees that pharmaceutical and medical device firms pay to fund regulatory approvals, a breakthrough for corporations arguing that public belt-tightening should not affect private money.

The U.S. Food and Drug Administration Safety Over Sequestration Act, or the FDA SOS Act, would free up $85 million in user fees that are being held in legal limbo, unable to be put toward deficit reduction and unable to be spent absent direction from Congress. The bill,...
To view the full article, register now.